Clinical Trial Update: Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial assessing preoperative chemotherapy with bevacizumab and PET-guided salvage therapy in locally advanced but resectable gastric and gastroesophagea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Esophageal Cancer, Gastric Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-02-03